Novo Nordisk said on Tuesday (June 25) its popular weight-loss drug Wegovy has been approved in China, paving the way for sales in the world’s second-largest economy.
Novo said in March that it would initially target Chinese patients willing to pay out-of-pocket for the weekly injectable drug.
The number of adults who are overweight in China is projected to reach 540 million by 2030, a rise of 2.8 times from 2000 levels, while those who are obese are expected to jump 7.5 times to 150 million, according to a 2020 study by Chinese public health researchers.
Ozempic won approval from China in 2021 and Novo saw sales of the drug in the greater China region double to 4.8 billion Danish crowns (698 million) last year. -Report from Reuters

For more ABS-CBN News videos, click the link below:
https://www.youtube.com/playlist?listPLgyY1WylJUmgUHWUpi2ioSp4xAP1SmAaf

For more latest news and analysis from ABS-CBN News videos, click the link below:
https://www.youtube.com/playlist?listPLgyY1WylJUmg4pcvfM9a96rbUcLD_0P_U

For more News Digital News Raw Cuts, click the link below:
https://www.youtube.com/playlist?listPLgyY1WylJUmi83yKJH8Dv0p_3D4cyZKzV

Subscribe to the ABS-CBN News channel! – http://bit.ly/TheABSCBNNews

Watch the full episodes of TV Patrol on iWantTFC:
http://bit.ly/TVPatrol-iWantTFC

Visit our website at http://news.abs-cbn.com
Facebook: https://www.facebook.com/abscbnNEWS
Twitter: https://twitter.com/abscbnnews

#Exclusive
#LatestNews
#ABSCBNNews

Take the opportunity to connect and share this video with your friends and family if you find it useful.